Category :   Corporate Information

INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

№12 3 2010 5

TREATMENT IN PATIENTS WITH METASTATIC COLORECTAL CANCER: PANITUMUMAB

Authors:Shparyk Y.V. №12 3 2010 2

TACTICS MANAGEMENT OF PATIENT WITH METASTATIC COLORECTAL CANCER WITH ISOLATED HEPATIC METASTASIS

Authors:Triapkin A.A. №12 2 2010 9

THE MODERN THERAPY POSSIBILITIES IN REPRODUCTIVE AGE OF WOMEN WITH CONSEQUENCES OF HYPERESTROGENITY

№12 2 2010 2

SUBSTANTIATION OF THE APPLICATION OF THE ANTIOXIDANTS IN THE PREOPERATIVE PHASE OF PATIENTS WITH THE CANCER OF THE LARYNGOPHARYNX

Authors:Yevchev F.D. №11 4 2009 5

USE OF FTORAFUR IN COMBINED TREATMENT OF BREAST CANCER

№11 2 2009 4

FARESTON® (ТOREMIFENE): MULTIPLE EFFECTS IN PRE-CANCER AND CANCER

№11 1 2009 7

TREATMENT OF MASTOPATHY IN MENOPAUSAL WOMEN

Authors:Aleksandrov A.I. Denisenko Y.V. Ishhenko R.V. №10 4 2008 42

FARESTON® (ТOREMIFENE) DOSE OPTIMIZATION IN TREATMENT OF PATIENTS WITH LOCAL FORMS OF DISHORMONAL MAMMARY DYSPLASIAS DEPENDING ON THE RECEPTOR STATUS

Authors:Shpon’ka I.S. Bondareva V.A. №10 4 2008 11

ANTIANDROGENS IN HORMONOTHERAPY OF PROSTATE CANCER PATIENTS

№10 2 2008 14

«1234»